These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

596 related items for PubMed ID: 26318019

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Is there long-term value of pathology scoring in immunoglobulin A nephropathy? A validation study of the Oxford Classification for IgA Nephropathy (VALIGA) update.
    Coppo R, D'Arrigo G, Tripepi G, Russo ML, Roberts ISD, Bellur S, Cattran D, Cook TH, Feehally J, Tesar V, Maixnerova D, Peruzzi L, Amore A, Lundberg S, Di Palma AM, Gesualdo L, Emma F, Rollino C, Praga M, Biancone L, Pani A, Feriozzi S, Polci R, Barratt J, Del Vecchio L, Locatelli F, Pierucci A, Caliskan Y, Perkowska-Ptasinska A, Durlik M, Moggia E, Ballarin JC, Wetzels JFM, Goumenos D, Papasotiriou M, Galesic K, Toric L, Papagianni A, Stangou M, Benozzi L, Cusinato S, Berg U, Topaloglu R, Maggio M, Ots-Rosenberg M, D'Amico M, Geddes C, Balafa O, Quaglia M, Cravero R, Lino Cirami C, Fellstrom B, Floege J, Egido J, Mallamaci F, Zoccali C, ERA-EDTA Immunonephrology Working Group.
    Nephrol Dial Transplant; 2020 Jun 01; 35(6):1002-1009. PubMed ID: 30418652
    [Abstract] [Full Text] [Related]

  • 23. The Oxford classification of IgA nephropathy: a retrospective analysis.
    Yau T, Korbet SM, Schwartz MM, Cimbaluk DJ.
    Am J Nephrol; 2011 Jun 01; 34(5):435-44. PubMed ID: 21968096
    [Abstract] [Full Text] [Related]

  • 24. Relationship between renal CD68+ infiltrates and the Oxford Classification of IgA nephropathy.
    Soares MF, Genitsch V, Chakera A, Smith A, MacEwen C, Bellur SS, Alham NK, Roberts ISD.
    Histopathology; 2019 Mar 01; 74(4):629-637. PubMed ID: 30303541
    [Abstract] [Full Text] [Related]

  • 25. The Oxford classification of IgA nephropathy: single centre experience.
    Grcevska L, Ristovska V, Nikolov V, Petrusevska G, Milovanceva-Popovska M, Polenakovic M.
    Prilozi; 2010 Mar 01; 31(2):7-16. PubMed ID: 21258273
    [Abstract] [Full Text] [Related]

  • 26. Predictors of outcome in paediatric IgA nephropathy with regard to clinical and histopathological variables (Oxford classification).
    Edström Halling S, Söderberg MP, Berg UB.
    Nephrol Dial Transplant; 2012 Feb 01; 27(2):715-22. PubMed ID: 21750154
    [Abstract] [Full Text] [Related]

  • 27. Mycophenolate Mofetil Combined With Prednisone Versus Full-Dose Prednisone in IgA Nephropathy With Active Proliferative Lesions: A Randomized Controlled Trial.
    Hou JH, Le WB, Chen N, Wang WM, Liu ZS, Liu D, Chen JH, Tian J, Fu P, Hu ZX, Zeng CH, Liang SS, Zhou ML, Zhang HT, Liu ZH.
    Am J Kidney Dis; 2017 Jun 01; 69(6):788-795. PubMed ID: 28215945
    [Abstract] [Full Text] [Related]

  • 28. Extracapillary proliferation is an independent predictive factor in Immunoglobulin A nephropathy.
    Serriello I, Polci R, Feriozzi S, Gigante A, Di Giulio S, Rosa M, Galliani M, Morosetti M, Pugliese F, Petitti T, Onetti Muda A, Giannakakis K.
    Nephrology (Carlton); 2015 Sep 01; 20(9):654-9. PubMed ID: 25943286
    [Abstract] [Full Text] [Related]

  • 29. Evidence from the Oxford Classification cohort supports the clinical value of subclassification of focal segmental glomerulosclerosis in IgA nephropathy.
    Bellur SS, Lepeytre F, Vorobyeva O, Troyanov S, Cook HT, Roberts IS, International IgA Nephropathy Working Group.
    Kidney Int; 2017 Jan 01; 91(1):235-243. PubMed ID: 27914703
    [Abstract] [Full Text] [Related]

  • 30. Oxford classification of immunoglobulin A nephropathy: an update.
    Roberts IS.
    Curr Opin Nephrol Hypertens; 2013 May 01; 22(3):281-6. PubMed ID: 23518465
    [Abstract] [Full Text] [Related]

  • 31. Mesangial C4d deposition may predict progression of kidney disease in pediatric patients with IgA nephropathy.
    Fabiano RCG, de Almeida Araújo S, Bambirra EA, Oliveira EA, Simões E Silva AC, Pinheiro SVB.
    Pediatr Nephrol; 2017 Jul 01; 32(7):1211-1220. PubMed ID: 28233100
    [Abstract] [Full Text] [Related]

  • 32. Immunoglobulin a nephropathy: Pathological markers of renal survival in paediatric patients.
    Fabiano RC, Pinheiro SV, de Almeida Araújo S, Simões E Silva AC.
    Nephrology (Carlton); 2016 Dec 01; 21(12):995-1002. PubMed ID: 27414046
    [Abstract] [Full Text] [Related]

  • 33. Mycophenolate mofetil therapy in immunoglobulin A nephropathy: histological changes after treatment.
    Beckwith H, Medjeral-Thomas N, Galliford J, Griffith M, Levy J, Lightstone L, Palmer A, Roufosse C, Pusey C, Cook HT, Cairns T.
    Nephrol Dial Transplant; 2017 Jan 01; 32(suppl_1):i123-i128. PubMed ID: 28391339
    [Abstract] [Full Text] [Related]

  • 34. Corticosteroids in IgA Nephropathy: A Retrospective Analysis from the VALIGA Study.
    Tesar V, Troyanov S, Bellur S, Verhave JC, Cook HT, Feehally J, Roberts IS, Cattran D, Coppo R, VALIGA study of the ERA-EDTA Immunonephrology Working Group.
    J Am Soc Nephrol; 2015 Sep 01; 26(9):2248-58. PubMed ID: 25677392
    [Abstract] [Full Text] [Related]

  • 35. A multicenter application and evaluation of the oxford classification of IgA nephropathy in adult chinese patients.
    Zeng CH, Le W, Ni Z, Zhang M, Miao L, Luo P, Wang R, Lv Z, Chen J, Tian J, Chen N, Pan X, Fu P, Hu Z, Wang L, Fan Q, Zheng H, Zhang D, Wang Y, Huo Y, Lin H, Chen S, Sun S, Wang Y, Liu Z, Liu D, Ma L, Pan T, Zhang A, Jiang X, Xing C, Sun B, Zhou Q, Tang W, Liu F, Liu Y, Liang S, Xu F, Huang Q, Shen H, Wang J, Shyr Y, Phillips S, Troyanov S, Fogo A, Liu ZH.
    Am J Kidney Dis; 2012 Nov 01; 60(5):812-20. PubMed ID: 22819700
    [Abstract] [Full Text] [Related]

  • 36. The association of microhematuria with mesangial hypercellularity, endocapillary hypercellularity, crescent score and renal outcomes in immunoglobulin A nephropathy.
    Bobart SA, Alexander MP, Shawwa K, Vaughan LE, Ghamrawi R, Sethi S, Cornell L, Glassock RJ, Fervenza FC, Zand L.
    Nephrol Dial Transplant; 2021 Apr 26; 36(5):840-847. PubMed ID: 31859353
    [Abstract] [Full Text] [Related]

  • 37. The use of the Oxford classification of IgA nephropathy to predict renal survival.
    Alamartine E, Sauron C, Laurent B, Sury A, Seffert A, Mariat C.
    Clin J Am Soc Nephrol; 2011 Oct 26; 6(10):2384-8. PubMed ID: 21885791
    [Abstract] [Full Text] [Related]

  • 38. Prognostic value of the Oxford classification and the Oxford score in IgA nephropathy: A Tunisian study.
    Jebali H, Ghabi H, Mami I, Kaab BB, Fatma LB, Smaoui W, Haouet S, Mahjouba HB, Hassan M, Hmida FB, Raies L, Zouaghi MK.
    Saudi J Kidney Dis Transpl; 2020 Oct 26; 31(6):1366-1375. PubMed ID: 33565449
    [Abstract] [Full Text] [Related]

  • 39. Treatment for IgA nephropathy with stage 3 or 4 chronic kidney disease: low-dose corticosteroids combined with oral cyclophosphamide.
    Ma F, Yang X, Zhou M, Bai M, Zhao L, Li L, Dong R, Liu C, Li R, Sun S.
    J Nephrol; 2020 Dec 26; 33(6):1241-1250. PubMed ID: 32447619
    [Abstract] [Full Text] [Related]

  • 40. The association of 5-year therapeutic responsiveness with long-term renal outcome in IgA nephropathy.
    Tsushima H, Samejima KI, Eriguchi M, Uemura T, Tasaki H, Fukata F, Nishimoto M, Kosugi T, Tanabe K, Okamoto K, Matsui M, Tsuruya K.
    Clin Exp Nephrol; 2022 Aug 26; 26(8):797-807. PubMed ID: 35426595
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 30.